Effect of the beta-adrenergic blocker pindolol on platelet function in chronic hypertensive pregnancy

Hypertension in Pregnancy

Volumn 15, Issue 2, 1996, Pages 193-202

  Hirsch, Michael ^a   Bar, Jacob ^a   Bott Kanner, Gustava ^a,b   Kaplan, Boris ^a   Fuchs, Jacob ^a   Ovadia, Jardena ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Beta adrenergic blocker; Chronic hypertension; Pindolol treatment; Platelet function; Pregnancy

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADRENALIN; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PINDOLOL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MATERNAL HYPERTENSION; ORAL DRUG ADMINISTRATION; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

EID: 0029837207     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641959609015702     Document Type: Article

References (23)

1. Beaufils M, Uzan S, Donsimoni R, Colav JC. Prevention of preeclampsia by early anti-platelet therapy. Lancet 1985; 1:840-2.
2. Wallenburg HC, Dekker GA, Makovitz JW, Rotmans P. Low dose aspirin prevents pregnancy induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet 1986;1:1-3.
3. 2 to prostacyclin in relatively high-risk pregnancies. New Engl J Med 1989;321:351-6.
4. Fletcher AE, Bulpitt CJ. A review of clinical trials in pregnancy. In: Rubin PC, ed. Hypertension in Pregnancy. New York: Elsevier, 1988: 186-201.
5. Barron WM, Murphy MD, Lindheimer MD. Management of hypertension during pregnancy. In: Laragh JH, Brenner BM, eds. Hypertension: Diagnosis and Management. New York: Raven Press, 1990: 1809-27.
6. Clark NJ, Meninger K, Bertholet A. Pindolol, the pharmacology of a partial agonist. Br J Clin Pharmacol 1982;13:149S-58S.
7. Lunell NO, Nylund L, Lewander R, Sarby B, Wager JJ. Uteroplacental blood flow in pregnancy hypertension after the administration of a beta-adernoceptor blocker, pindolol. Gynecol Obstet Invest 1984;18:269-74.
8. Nathan I, Dvilansky A, Sage BJ, Korczyn AD. Effects of propranolol and pindolol on platelet aggregation and serotonin release. Life Sci 1977;20:407-12.
9. Greer IA, Walker JJ, McLaren M, Calder AA, Forbes CD. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation. Thromb Haemostas 1985;54:480-4.
10. Winter K, Trap-Jensen J. Effects of three beta-blockers with different pharmacodynamic properties on platelet aggregation and platelet and plasma cyclic AMP. Eur J Clin Pharmacol 1988;35:17-20.
11. Bott-Kanner G, Hirsch M, Friedman S, Boner J, Ovadia J, Merlob P, Mor N, Modan M, Galai N, Rosenfeld JB. Anti-hypertensive therapy in the management of hypertension in pregnancy - a clinical double-blind study of pindolol. Clin Exp Hypertens 1992;11:207-220.
12. Born GVR. Effect of numbers and sizes of platelet aggregates on the optical density of plasma. Nature 1962;194:927.
13. DeLuca M, McElroy WD. Kinetics of firefly luciferase catalysed reactions. Biochemistry 1974;19:921-5.
14. Feinman RD, Lubowsky J, Charo I, Zabinski MP. The lumiaggregometer: a new instrument for simultaneous measurement of secretion and aggregation of platelets. J Lab Clin Med 1977;90:125-9.
15. Belch JJF, Walker J, McLaren M, Calder A, Forbes CD, Prentice CRM. Labetalol and platelets in pregnancy induced hypertension. In: Lewis PJ, Moncada S, O'Grady J, eds. Prostacyclin in Pregnancy. New York: Raven Press, 1983: 207-10.
16. Morrison R, Crawford J, Macpherson M, Hepstistall S. Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy induced hypertension. Thromb Haemostas 1985;54:607-11.
17. O'Brien WF, Saba HI, Knuppel RA, Scerbo JC, Cohen GR. Alterations in platelet concentration and aggregation in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1986;155:486-90.
18. Whigham KAE, Hoeie PW, Drummond AH, Prentice CRM. Abnormal platelet function in pre-eclampsia. Br J Obstet Gynecol 1978;85:28-32.
19. Ahmed Y, Sullivan MHF, Elder MG. Detection of platelet desensitization in pregnancy-induced hypertension is dependent on the agonist used. Thromb Haemostas 1991; 65:474-7.
20. Prentice CRM. Coagulopathy of preeclampsia. In: Lewis PJ, Moncada S, O'Grady J, eds. Prostacyclin in Pregnancy. New York: Raven Press, 1983: 175-81.
21. Chesley LC. History and epidemiology of pre-eclampsia. Clin Obstet Gynecol 1984; 27:801-35.
22. Sibai BM, Caritis SN, Thom E, Keebanoff M, McNellis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M, et al. Prevention of pre-eclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993;329:1213-8.
23. CLASP Collaborative Group. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:619-29.